Lead Product(s) : Water
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : HydraVes Technologies Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
The Effect of Proprietary Water on Physiological and Perceptual Responses
Details : Water is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Dehydration.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 11, 2022
Lead Product(s) : Water
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : HydraVes Technologies Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Water
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Lund University | Danone Global Research & Innovation Center
Deal Size : Inapplicable
Deal Type : Inapplicable
The Hydration to Optimize Metabolism (H2O Metabolism) Pilot Study
Details : Water is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Dehydration.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
July 02, 2018
Lead Product(s) : Water
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Lund University | Danone Global Research & Innovation Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Water
Therapeutic Area : Endocrinology
Study Phase : Undisclosed
Sponsor : Lund University | Danone Global Research & Innovation Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Hydration to Optimize Metabolism
Details : Water is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperglycemia.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 06, 2018
Lead Product(s) : Water
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Sponsor : Lund University | Danone Global Research & Innovation Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Water
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : HYD is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
September 17, 2014
Lead Product(s) : Water
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
